OneWater Marine Closes Bio-Chem Sale, Adjusts 2026 Forecast

[Para 1: The Lead] OneWater Marine (OWMN) has finalized the sale of its ocean bio-chemistry division, a move aimed at streamlining operations. The company announced a 10% reduction in its 2026 financial forecast, citing the sale's impact on its revenue model. The transaction, completed on February 3, 2026, is expected to result in a $5M gain, boosting immediate financial health. [Para 2-3: Supporting details & Context] OWMN's decision to divest the bio-chemistry unit is part of a broader strategy to focus on core marine technology solutions. The sale, completed for $20M, is anticipated to improve operational efficiency and reduce overhead. The revised forecast, now $120M, reflects the immediate financial benefits of the sale while accounting for the loss of bio-chemistry division revenues. Shareholders are advised to monitor the company's upcoming earnings call for further details on the strategic shift and its implications for future growth.